Intermittent fasting versus continuous caloric restriction for glycemic control and weight loss in type 2 diabetes: A traditional review
Lakhani HA, Biswas D, Kuruvila M, Chava MS, Raj K, Varghese JT, Swathi NL
Primary care diabetes · 2 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2025-02-24 · Prim Care Diabetes · vol. 19 · número 3 · págs. 203–213
- Editorial
- Elsevier BV
- Citado
- 6 citas · más que el 91% de estudios similares · 3.2× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 86 trabajos
- Acceso
- De pago
- Áreas de investigación
- Dietary Effects on Health · Diet and metabolism studies · Diabetes Management and Research
- Palabras clave
- intermittent fasting, type 2 diabetes, glycemic control, weight loss, HbA1c, fasting blood glucose, insulin sensitivity, visceral fat, autophagy, fat metabolism, dietary intervention, medication adherence, safety
- MeSH
- humans, diabetes mellitus, type 2, weight loss, blood glucose, treatment outcome, caloric restriction, fasting, time factors, biomarkers, glycemic control, glycated hemoglobin, intermittent fasting
7 autores
- Hairya Ajaykumar Lakhani🇮🇳Suamandeep Vidyapeeth University
- Deepanwita Biswas🇮🇳Bharati Vidyapeeth (Deemed to be University)
- Mahima Kuruvila
- Manisha Sai Chava🇮🇳Kakatiya Medical College
- Kshitij Raj
- Joel Thomas Varghese🇦🇪Ras al-Khaimah Medical and Health Sciences University
- Nadipineni Swathi🇮🇳Jawaharlal Nehru Technological University Anantapur
Resumen
El texto original del estudio, en el idioma en que se publicó.
Type 2 Diabetes Mellitus (T2DM) represents a major global health issue, with its incidence anticipated to increase markedly in the forthcoming decades. Efficient non-pharmacological therapies, especially dietary approaches, are essential for regulating glycemic control and facilitating weight reduction. Intermittent Fasting (IF) and Continuous Caloric Restriction (CCR) are two well researched methodologies, but their relative effectiveness and enduring advantages continue to be topics of active discussion. This review systematically assesses and contrasts the impacts of intermittent fasting (IF) and continuous calorie restriction (CCR) on glycemic regulation and weight reduction in persons with type 2 diabetes mellitus (T2DM), highlighting their short-term and long-term effects, safety profiles, and adherence rates. A thorough literature analysis was performed utilizing PubMed and Google Scholar, concentrating on papers published from 2000 to 2024. The review encompassed randomized controlled trials and observational studies that investigated the effects of intermittent fasting (IF) and continuous calorie restriction (CCR) on glycemic indicators (HbA1c, fasting glucose) and body weight. IF shown substantial short-term advantages, encompassing marked decreases in HbA1c levels, fasting glucose, and body weight. Mechanistic discoveries emphasized better insulin sensitivity, augmented fat metabolism, and autophagy as key aspects. In contrast, CCR was linked to enduring metabolic enhancements, including decreased visceral fat and improved insulin sensitivity. Nevertheless, both dietary approaches demonstrated constraints.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.